Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was sold at an average price of $11.35, for a total value of $340,500.00. Following the sale, the insider now directly owns 1,696,097 shares of the company’s stock, valued at approximately $19,250,700.95. This trade represents a 1.74 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, October 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.77, for a total value of $323,100.00.
• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The stock was sold at an average price of $9.02, for a total value of $63,807.48.

Alignment Healthcare Stock Performance

ALHC stock traded down $1.35 during trading on Friday, hitting $11.49. The company had a trading volume of 15,157,138 shares, compared to its average volume of 1,107,887. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a 50-day moving average price of $11.55 and a 200-day moving average price of $9.31. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $14.25. The firm has a market cap of $2.20 billion, a PE ratio of -14.92 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $692.43 million for the quarter, compared to analysts’ expectations of $662.11 million. During the same quarter in the previous year, the firm posted ($0.19) EPS. The firm’s quarterly revenue was up 51.6% on a year-over-year basis. On average, analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. UBS Group raised their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 30th. Piper Sandler reiterated an “overweight” rating and issued a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. KeyCorp began coverage on Alignment Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Robert W. Baird lifted their target price on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. Finally, Stifel Nicolaus lifted their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a report on Friday, July 26th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Alignment Healthcare during the 1st quarter worth approximately $918,000. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock worth $45,828,000 after acquiring an additional 93,262 shares in the last quarter. Deerfield Management Company L.P. Series C boosted its stake in shares of Alignment Healthcare by 31.8% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after acquiring an additional 2,630,788 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Alignment Healthcare by 27.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 382,462 shares of the company’s stock worth $2,991,000 after acquiring an additional 82,559 shares in the last quarter. Finally, Hood River Capital Management LLC boosted its stake in shares of Alignment Healthcare by 6.4% during the 2nd quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock worth $24,294,000 after acquiring an additional 185,854 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.